Third country's Army may enter Kashmir on behalf of Pak: China

Agencies
July 10, 2017

Beijing, Jul 10: A "third country's" Army could enter Kashmir at Pakistan's request, using the "same logic" the Indian Army used to stop the Chinese military from constructing a road in the Doklam area in the Sikkim sector on behalf of Bhutan, an analyst at a Chinese think tank said.

china"Even if India were requested to defend Bhutan's territory, this could only be limited to its established territory, not the disputed area," Long Xingchun, Director at the Centre for Indian Studies at China West Normal University, said in the article he wrote in the Global Times.

"Otherwise, under India's logic, if the Pakistani government requests, a third country's Army can enter the area disputed by India and Pakistan, including India-controlled Kashmir," the article said.

The Chinese state media have carried a barrage of critical articles on the Doklam standoff criticising India, but this was the first time Pakistan and Kashmir have been brought into the narrative.

"Indian troops invaded China's Doklam area in the name of helping Bhutan, but in fact the invasion was intended to help India by making use of Bhutan," it said, referring to the June 30 statement issued by India's External Affairs Ministry.

China and India have been engaged in a standoff in the Doklam area near the Bhutan tri-junction for the past three weeks after a Chinese Army's construction party attempted to build a road. Doka La is the Indian name for the region which Bhutan recognises as Doklam, while China claims it as part of its Donglang region. Of the 3,488-km-long India-China border from Jammu and Kashmir to Arunachal Pradesh, a 220-km section falls in Sikkim.

"For a long time, India has been talking about international equality and non-interference in the internal affairs of others, but it has pursued hegemonic diplomacy in South Asia, seriously violating the UN Charter and undermining the basic norms of international relations," it said.

"Through mass immigration to Sikkim, ultimately leading to control of the Sikkim parliament, India annexed Sikkim as one of its states," it alleged. "This incursion reflects that India fears China can quickly separate mainland India from northeast India through military means, dividing India into two pieces," it said.

"In this case, northeast India might take the opportunity to become independent. India has interpreted China's infrastructure construction in Tibet as having a geopolitical intention against India. India itself is unable to do the same for its northeastern part, so it is trying to stop China's road construction," it said.

"India's incursion, based on its own strategic judgment, is a clear violation of international law," the article said, claiming that the western countries will not unconditionally support India as they have a wide range of "common interests" with China. "As for the territorial dispute between China and Bhutan, it should be resolved by both sides and India must respect Bhutan's sovereignty," it said.

"China can show the region and the international community or even the UN Security Council its evidence to illustrate China's position. It highlights China's sincerity and effort to maintain peace as a responsible big power. It will never resort to force till it is the last choice," it said.

Another article in the same daily said India must desist using the "Dalai Lama card" and mess up relations with China.

Referring to reports that the "Tibetan national flag," a pro-independence symbol adopted by the Tibetan government-in- exile, was unfurled on the shores of Bangong Lake, known as Pangong Tso Lake in India's in Ladakh region, the article said the timing on the incident coincided with the standoff between the two militaries in Doklam area and whether Indian authorities instigated the political activity of Tibetan separatists to exert pressure on China.

"The lake sits astride India and China, with the Line of Actual Control passing through it. It's the first time the Tibetan exile administration in northern India has flown the flag at this location," it said.

"The timing of the flag-hoisting on Indian territory has sparked wide speculation over whether the Indian authorities instigated the political activity of Tibetan separatists to exert pressure on China. Although the involvement of New Delhi remains unclear, we hope they did not send any signal of approval," it said.

"New Delhi publicly promises not to allow any anti-China political activities by Tibetan exiles on Indian territory. But it has long used the Tibet question as a diplomatic card in dealing with Beijing," it said.

"When the Indian government attaches great importance to its relationship with China, it keeps a tight grip on anti- China political activities on its soil. However, when it is dissatisfied or has conflicts with Beijing, the Tibet card is played up. But India may overestimate the influence of Tibetan exiles," it said.

"With the rise of China and as Tibet becomes better off, Tibetan independence runs counter to the will of Tibetans. The space for Tibetan separatists has been largely squeezed as more Western countries have snubbed the Dalai Lama. The Tibet card is gradually losing its value," it said.

"If New Delhi is pulling the strings of the Tibetan exiles' political act of flag-hoisting, it will only have burned itself. Both border issues and the Tibet question concern China's core interests and China won't yield to provocations," it said. Given the ongoing border spat, Indian should "act prudently" to avoid escalating tensions, it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 6,2020

Washington, Jun 6: US President Donald Trump has said that countries like India and China would have much more coronavirus cases than America, the worst-hit country in the world, if they conduct more tests.

Trump, in his remarks at Puritan Medical Products in Maine, said that the US has carried out 20 million tests.

Compared to the US, Germany is at four million and much talked about South Korea is about three million tests, he said on Friday.

According to Johns Hopkins Coronavirus Resource Center, the US has reported nearly 1.9 million cases and over 1,09,000 deaths, making America the worst affected country, while the total number of coronavirus cases in India and China stand at 2,36,184 and 84,177 respectively.

India has so far conducted over 4 million coronavirus tests, according to the health ministry.

Commenting on the COVID-19 tests in the US, Trump said: "We will be well over 20 million tests. Remember this, when you test more, you have more cases.

"I say to my people every time we test; you find cases because we do more testing. If we have more cases, if we wanted to do testing in China or in India or other places, I promise you there would be more cases... you are doing a fantastic job in getting out the swabs".

Puritan is one of the only manufacturers in the world producing the high-quality medical swabs that are crucial for rapid testing.

"And every swab you make at Puritan is proudly stamped with the beautiful phrase made in the USA."

"Thanks to the testing capacity that you are making possible, our country is reopening and our economy is recovering like nobody would've thought possible," he said.

Referring to the latest monthly employment numbers, Trump said that the economy is now back on track.

"We absolutely shattered expectations, and this is the largest monthly jobs increase in American history, think of that; that's a long time.

"I think it's more than double or about double of what our highest was before so this is the largest monthly job increase in American history. And we're going to have a phenomenal next year. We're going to have a tremendous couple of months prior to the election on November 3 very, very important date," the president said.

Seeking re-election for his second consecutive term, Trump is pitted against Democratic presidential nominee Joe Biden in November 3 presidential elections. Most of the opinion polls shows that Biden is several points ahead of Trump.

"It's going to be a very important election because the only thing that can screw it up is if you get the wrong president and they raise your taxes, and they open up your borders so that everybody pours into our country," Trump said.

Reiterating that he has built a strong economy in the last three years, Trump vowed to bring the economy back on track, which has been badly hit by the coronavirus pandemic.

Describing the fight against coronavirus as the greatest national and industrial mobilisation since the World War II, Trump said that his administration has marshaled the full power of the US government and US industry to defeat the invisible enemy.

"It is indeed an enemy. It came from China, should have been stopped in China. They didn't do that," he alleged.

The administration, he said, has delivered over 1.5 billion pieces of personal protective equipment to doctors and nurses on the front lines. "We slashed the red tape to speed up the development of vaccines. And vaccines are coming along incredibly well, wait till you see, and therapeutics. And we partnered at private sector leaders such as Puritan to build the largest and most advanced testing capacity on the face of the earth, like this one," he said.

The Puritan factory in Maine, he said, quickly ramped up the production to produce nearly 20 million foam tipped swabs each month.

"Then in April, my administration invoked the Defence Production Act to help you scale up even more. Under a USD 75 million public-private partnership, Puritan will soon double production to 40 million swabs per month," Trump added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 21,2020

Beijing, Mar 21: China reported no domestically transmitted coronavirus cases for the third consecutive day even as seven more fatalities have been confirmed, taking the death toll in the country to 3255.

No new domestically transmitted cases of COVID-19 were reported on the Chinese mainland for the third day in a row on Friday, China's National Health Commission (NHC) said on Saturday.

The overall confirmed cases on the mainland had reached 81,008 by the end of Friday, which included 3,255 who died, 6,013 patients still undergoing treatment, 71,740 patients who had been discharged after recovery, the NHC said.

The NHC said 41 new confirmed COVID-19 cases were reported on the Chinese mainland on Friday from the people arriving from abroad, taking the total number of imported cases to 269.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.